GFC Life Science Co., Ltd (KOSDAQ:388610)
14,300
+10 (0.07%)
At close: Aug 4, 2025, 3:30 PM KST
GFC Life Science Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 |
---|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 |
Cash & Equivalents | 1,186 | 141.89 | 977.2 | 1,241 | 2,601 | Upgrade |
Short-Term Investments | 24 | 493.54 | 528.86 | - | - | Upgrade |
Cash & Short-Term Investments | 1,210 | 635.43 | 1,506 | 1,241 | 2,601 | Upgrade |
Cash Growth | 90.42% | -57.81% | 21.37% | -52.30% | -48.29% | Upgrade |
Accounts Receivable | 1,714 | 1,831 | 1,783 | 1,315 | 1,694 | Upgrade |
Other Receivables | 2.51 | 7.23 | 240.38 | 80.64 | 9.66 | Upgrade |
Receivables | 1,717 | 1,839 | 2,023 | 1,598 | 1,886 | Upgrade |
Inventory | 632.12 | 671 | 481.4 | 891.09 | 417.78 | Upgrade |
Prepaid Expenses | 72.38 | 245.77 | 37.73 | 2.42 | 2.14 | Upgrade |
Other Current Assets | 67.84 | 72.01 | 88.64 | 105.19 | 90.88 | Upgrade |
Total Current Assets | 3,699 | 3,463 | 4,137 | 3,838 | 4,998 | Upgrade |
Property, Plant & Equipment | 12,797 | 16,057 | 14,698 | 11,517 | 6,112 | Upgrade |
Long-Term Investments | 824.84 | 624.67 | 425.48 | 4,135 | 3,607 | Upgrade |
Other Intangible Assets | 193.63 | 193.34 | 252 | 247.35 | 280.24 | Upgrade |
Other Long-Term Assets | 508.45 | 629.85 | 628.57 | 142.78 | 475.27 | Upgrade |
Total Assets | 18,023 | 20,967 | 20,141 | 19,880 | 15,472 | Upgrade |
Accounts Payable | 303.07 | 430.56 | 440.44 | 314.63 | 376.06 | Upgrade |
Accrued Expenses | 356.64 | 336.87 | 203.6 | 112.33 | 98.02 | Upgrade |
Short-Term Debt | 5,084 | 1,580 | 500 | - | - | Upgrade |
Current Portion of Long-Term Debt | 320.8 | 5,336 | 336.12 | 896.12 | 1,640 | Upgrade |
Current Income Taxes Payable | - | - | 15.94 | - | 5 | Upgrade |
Current Unearned Revenue | 14.14 | 14.14 | 21.55 | 21.17 | 204.59 | Upgrade |
Other Current Liabilities | 919.21 | 2,436 | 893.84 | 749.92 | 692.22 | Upgrade |
Total Current Liabilities | 6,998 | 10,133 | 2,411 | 2,094 | 3,016 | Upgrade |
Long-Term Debt | 2,021 | 3,384 | 7,620 | 6,256 | 1,845 | Upgrade |
Other Long-Term Liabilities | 70 | 50 | 20 | 239.54 | 222.54 | Upgrade |
Total Liabilities | 9,788 | 14,130 | 10,239 | 8,700 | 5,157 | Upgrade |
Common Stock | 518.26 | 518.26 | 518.26 | 518.26 | 518.26 | Upgrade |
Additional Paid-In Capital | 8,864 | 8,864 | 8,864 | 8,864 | 7,400 | Upgrade |
Retained Earnings | 418.77 | -1,128 | 1,804 | 1,617 | 2,252 | Upgrade |
Treasury Stock | -200 | -200 | - | - | - | Upgrade |
Comprehensive Income & Other | -1,546 | -1,397 | -1,465 | -0 | -0 | Upgrade |
Total Common Equity | 8,055 | 6,657 | 9,721 | 10,999 | 10,170 | Upgrade |
Shareholders' Equity | 8,235 | 6,838 | 9,902 | 11,180 | 10,315 | Upgrade |
Total Liabilities & Equity | 18,023 | 20,967 | 20,141 | 19,880 | 15,472 | Upgrade |
Total Debt | 7,426 | 10,300 | 8,456 | 7,152 | 3,485 | Upgrade |
Net Cash (Debt) | -6,216 | -9,665 | -6,950 | -5,912 | -883.75 | Upgrade |
Net Cash Per Share | -5996.61 | -9325.18 | -6707.09 | -11409.48 | -852.24 | Upgrade |
Filing Date Shares Outstanding | 1.04 | 1.04 | 1.04 | 0.52 | 1.04 | Upgrade |
Total Common Shares Outstanding | 1.04 | 1.04 | 1.04 | 0.52 | 1.04 | Upgrade |
Working Capital | -3,299 | -6,670 | 1,725 | 1,744 | 1,982 | Upgrade |
Book Value Per Share | 7770.77 | 6423.20 | 9381.36 | 21228.83 | 9807.69 | Upgrade |
Tangible Book Value | 7,861 | 6,464 | 9,469 | 10,752 | 9,890 | Upgrade |
Tangible Book Value Per Share | 7583.97 | 6236.66 | 9138.18 | 20751.44 | 9537.44 | Upgrade |
Land | 3,813 | 4,770 | 4,770 | 5,148 | 3,500 | Upgrade |
Buildings | 6,319 | 8,499 | 6,137 | 4,793 | 2,047 | Upgrade |
Machinery | 5,455 | 4,951 | 3,441 | 1,321 | 1,203 | Upgrade |
Construction In Progress | 18.93 | 44.61 | 2,534 | 1,223 | 460.46 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.